research use only
Cat.No.S5749
| Related Targets | Adrenergic Receptor AChR 5-HT Receptor COX Calcium Channel Histamine Receptor GABA Receptor TRP Channel Cholinesterase (ChE) GluR |
|---|---|
| Other Dopamine Receptor Inhibitors | MPTP Hydrochloride Trifluoperazine Trifluoperazine 2HCl Penfluridol Rotundine Domperidone Sulpiride Azaperone ONC206 SCH-23390 hydrochloride |
|
In vitro |
DMSO
: 64 mg/mL
(200.71 mM)
Ethanol : 64 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 318.86 | Formula | C17H19ClN2S |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 50-53-3 | -- | Storage of Stock Solutions |
|
|
| Synonyms | CPZ | SMILES | CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl | ||
Read more about storage stability stock solution CAS number SMILES
| In vitro |
Chlorpromazine exerts a mild decrease in sEV uptake in only one MM cell line, indicating that the uptake of BMSC-derived sEVs by suspension MM cells may not rely on this compound-targeted receptors. |
|---|---|
| In vivo |
Chlorpromazine suppresses the growth of endometrial cancer (EC) tumors in vivo at a low dose with no signs of toxicity. |
References |
|
(data from https://clinicaltrials.gov, updated on 2025-11-18)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05431595 | RECRUITING | Delirium; Epileptics; Neuroleptics |
M.D. Anderson Cancer Center |
2022-07-19 | PHASE2; PHASE3 |
| NCT07364344 | NOT_YET_RECRUITING | Acute Ischemic Stroke |
Ji Xunming,MD,PhD |
2026-01 | |
| NCT06663631 | RECRUITING | Acute Ischemic Stroke |
Capital Medical University |
2024-11-09 | PHASE1 |
| NCT06238089 | Recruiting | Intellectual Disability |
University of Plymouth|Peninsula Clinical Trials Unit |
2023-12-19 | -- |
| NCT05190315 | COMPLETED | Glioblastoma Multiforme |
Mohammed Milhem |
2022-01-28 | PHASE1 |
| NCT05433402 | WITHDRAWN | Colon Cancer Stage III |
Sadat City University |
2022-07-20 | PHASE1; PHASE2 |
Read more about Clinical Trials
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.